Efficacy and Safety of Alirocumab in Patients With Hypercholesterolemia Not Adequately Controlled With Non-statin Lipid Modifying Therapy or the Lowest Strength of Statin
PHASE3
Primary Objective:
To demonstrate the reduction of low-density lipoprotein...
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin
PHASE2
This study investigates the safety, pharmacokinetics and effects of GSK1292...
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia (ODYSSEY COMBO I)
PHASE3
Alirocumab (SAR236553/REGN727) is a fully human monoclonal antibody that bi...
A Study of LY3015014 in Healthy Participants With High Cholesterol
PHASE1
This is a study in healthy participants with high levels of "bad" cholester...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.